Publication Cover
Human Fertility
an international, multidisciplinary journal dedicated to furthering research and promoting good practice
Volume 17, 2014 - Issue 3
500
Views
5
CrossRef citations to date
0
Altmetric
INVITED REVIEWS

Defining what is normal at menopause: How women's and clinician's different understandings may lead to a lack of provision for those in most need

Pages 218-222 | Received 15 Mar 2013, Accepted 07 Dec 2013, Published online: 03 Jul 2014

References

  • Ayers, B., Smith, M., Hellier, J., Mann, E., & Hunter, M. S. (2012). Effectiveness of group and self-help cognitive behavior therapy in reducing problematic menopausal hot flushes and night sweats (MENOS 2): a randomized controlled trial. Menopause, 19, 749–759.
  • Ballard, K.D., Kuh, D.J., & Wadsworth, M.E.J. (2001). The role of the menopause in women's experiences of the “change of life”. Sociology of Health & Illness, 23, 397–424.
  • Berecki-Gisolf, J., Begum, N., & Dobson, A.J. (2009). Symptoms reported by women in midlife: menopausal transition or aging?Menopause, 16, 1021–1029.
  • Blaxter, M. (2004). Health. Cambridge: Polity Press.
  • Blümel, J.E., Chedraui, P., Baron, G., Belzares, E., Bencosme, A., Calle, A., et al. (2011). A large multinational study of vasomotor symptom prevalence, duration, and impact on quality of life in middle-aged women. Menopause, 18, 778–785.
  • Bush, T.M., Bonomi, A.E., Nekhlyudov, L., Ludman, E.J., Reed, S.D., Connelly, M.T., et al. (2007). How the Women's Health Initiative (WHI) influenced physicians’ practice and attitudes. Journal of General Internal Medicine, 22, 1311–1316.
  • Charkoudian, N. (2003). Skin blood flow in adult human thermoregulation: how it works, when it does and why. Mayo Clinic Proceedings, 78, 603–612.
  • Conrad, P. (1992). Medicalization and Social Control. Annual Review of Sociology, 18, 209–232.
  • Deecher, D.C. (2009). Thermoregulation and menopause: Under standing the basic pathophysiology of vasomotor symptoms. In Soares C.N. & Warren M. (Eds). The Menopausal Transition Interface between Gynecology and Psychiatry Key Issues in Mental Health, vol. 175, Karger: Basel, pp. 77–87.
  • Freedman, R.R. (2002). Hot flash trends and mechanisms. Menopause, 9, 151–152.
  • Freedman, R.R. (2005). Hot flashes: Behavioral treatments, mechanisms, and relation to sleep. American Journal of Medicine, 118, 124S–130S.
  • Gayet-Ageron, A., Amamra, N., Ringa, V., Tainturier, V., Berr, C., Clavel-Chapelon, F., et al. (2005). Estimated numbers of postmenopausal women treated by hormone therapy in France. Maturitas, 52, 296–305.
  • Graziottin, A. (2005). The woman patient after WHI. Maturitas, 51, 29–37.
  • Hersh, A.L., Stefanick, M.L., & Stafford, R.S. (2004). National use of postmenopausal hormone therapy: annual trends and response to recent evidence. Journal of the American Medical Association, 291, 47–53.
  • Hyde, A., Nee, J., Howlett, E., Drennan, J., & Butler, M. (2010). Menopause narratives: the interplay of women's embodied experiences with biomedical discourses. Qualitative Health Research, 20, 805–815. doi:10.1177/1049732310363126.
  • Kaufert, P.A., & Gilbert, P. (1986). Women, menopause and medicalization. Culture, Medicine and Psychiatry, 10, 7–21.
  • Kronenberg, F. (1990). Hot Flashes: epidemiology and physiology. Annals of the New York Academy of Sciences, 592, 52–86.
  • Lakey, S.L., Reed, S.D., Lacroix, A.Z., Grothaus, L., & Newton, K.M. (2010). Self-reported changes in providers’ hormone therapy prescribing and counseling practices after the women's health initiative. Journal of Women's Health, 19, 2175–2181.
  • MacLennan, A.H. (2009). Hormone replacement therapy: a 2008 perspective. Obstetrics, Gynaecology and Reproductive Medicine, 19, 13–18.
  • Million Women Study Collaborators. (2003). Breast cancer and hormone replacement therapy in the Million Women Study. Lancet, 362, 419–427.
  • Mishra, G., Kok, H., Ecob, R., Cooper, R., Hardy, R., & Kuh, D. (2006). Cessation of hormone replacement therapy after reports of adverse findings from randomized controlled trials: evidence from a british birth cohort. American Journal of Public Health, 96, 1219–1225.
  • Morris, M.E., & Symonds, A. (2004). “We've been trained to put up with it’: real women and the menopause. Critical Public Health, 14, 311–323.
  • Moynihan, R. (2002). Too much medicine?BMJ, 324, 859–860.
  • Nelson, H.D. (2008). Menopause. The Lancet, 371, 760–770.
  • Palacios, S., Henderson, V.W., Siseles, N., Tan, D., & Villaseca, P. (2010). Age of menopause and impact of climacteric symptoms by geographical region. Climacteric, 13, 419–428.
  • Panay, N. (2012). Commentary regarding recent Million Women Study critique and subsequent publicity. Menopause International, 18, 33–35.
  • Pharm, M.-P.G.B., Dragomir, A., Pilon, D., Moride, Y., & Perreault, S. (2007). Changes in pattern of use, clinical characteristics and persistence rate of hormone replacement therapy among postmenopausal women after the WHI publication. Pharmacoepidemiology and Drug Safety, 16, 17–27.
  • Rook, K.S., Catalano, R., & Dooley, D. (1989). The timing of major life events: effects if departing from the social clok. American Journal of Community Psychology, 17, 223–258.
  • Rubinstein, H. (2012). The social construction of menopause: from deficiency disease to confusion? Conference Paper at the Interdisciplinary Workshop on Reproduction, Cambridge: Centre for Research in the Arts, Social Science and Humanities 20/11/2012.
  • Rubinstein, H.R. & Foster, J.L. (2012). “I don't know whether it is to do with age or to do with hormones and whether it is do with a stage in your life”: Making sense of menopause and the body. Journal of Health Psychology, 18, 292–307.
  • Shapiro, S., Farmer, R.D.T., Seaman, H., Stevenson, J.C., & Mueck, A.O. (2011). Does Hormone Replacement Therapy Cause Breast Cancer? An Application of Causal Principles to Three Studies Part 1. The Collaborative Reanalysis. Journal of Family Planning and Reproductive Health Care, 37, 103–109.
  • Stevenson, J.C. (2013). HRT should be used for primary prevention in the asymptomatic healthy postmenopausal woman. Presentation at the British Menopause Society 23rd Annual Conference, Stratford-on-Avon.
  • Stuenkel, C.A., Gass, M.L.S., Manson, J.E., Lobo, R.A., Pal, L., Rebar, R.W., & Hall, J.E. (2012). A decade after the Women’s Health Initiative-the experts do agree. Menopause-the Journal of the North American Menopause Society, 19, 846–847.
  • Watkins, E.S. (2007). The Oestrogen Elixir: A History of Hormone Replacement Therapy in America. Baltimore: The John Hopkins University Press.
  • Williams, R.E., Kalilani, L., DiBenedetti, D.B., Zhou, X., Fehnel, S.E., & Clark, R.V. (2007). Healthcare seeking and treatment for menopausal symptoms in the United States. Maturitas, 58, 348–358.
  • Writing Group for the Women's Health Initiative Investigators. (2002). Risks and benefits of oestrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative random controlled trial. Journal of the American Medical Association, 288, 321–333.
  • Ziv-Gal, A. & Flaws, J.A. (2010). Factors that may influence the experience of hot flushes by healthy middle-aged women. Journal of Women's Health, 19, 1905–1914.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.